Maryland House Bill 1147 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 4-0)
Status: Introduced on February 10 2023 - 25% progression, died in committee
Action: 2023-02-22 - Hearing 3/03 at 1:00 p.m. (Economic Matters) and Hearing canceled (Health and Government Operations)
Pending: House Economic Matters Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the cannabis oversight agency to, by regulation, establish a procedure to ensure that no individual who has been diagnosed with cannabis-induced psychosis may purchase cannabis or cannabis products through the State's medical cannabis program or adult-use cannabis program; and requiring the cannabis oversight agency to, by regulation, prohibit any cannabis or cannabis product sold through the State's adult-use cannabis program from containing greater than a 15% concentration of delta-9-tetrahydrocannabinol.

Public Health - Cannabis Programs - Cannabis-Induced Psychosis and THC Concentration Limit

Del. Nino Mangione [R]

Del. Brian Chisholm [R]

Del. Jeff Ghrist [R]

Del. Susan McComas [R]

Date	Chamber	Action
2023-02-22	House	Hearing 3/03 at 1:00 p.m. (Economic Matters) and Hearing canceled (Health and Government Operations)
2023-02-15	House	Hearing 3/03 at 1:00 p.m. (Economic Matters) and Hearing 3/07 at 1:00 p.m. (Health and Government Operations)
2023-02-10	House	Hearing 3/03 at 1:00 p.m. (Economic Matters)
2023-02-10	House	First Reading Economic Matters and Health and Government Operations

Chapter	Article	Section	Citation Type	Statute Text
Health - General	13	3302	(n/a)	See Bill Text
Health - General	23	101	(n/a)	See Bill Text
Health - General	23	102	(n/a)	See Bill Text
Health - General	23	103	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1147?ys=2023RS
Text	https://mgaleg.maryland.gov/2023RS/bills/hb/hb1147f.pdf